Connection

MINI MICHAEL to Child

This is a "connection" page, showing publications MINI MICHAEL has written about Child.
Connection Strength

0.306
  1. Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial. Am J Kidney Dis. 2023 Feb; 81(2):145-155.e1.
    View in: PubMed
    Score: 0.046
  2. Medical Nutrition Therapy for Pediatric Kidney Stone Prevention, Part 3: Cystinuria. J Ren Nutr. 2017 05; 27(3):e19-e21.
    View in: PubMed
    Score: 0.032
  3. Medical Nutrition Therapy for Pediatric Kidney Stone Prevention, Part Two. J Ren Nutr. 2017 03; 27(2):e11-e14.
    View in: PubMed
    Score: 0.032
  4. Medical Nutrition Therapy for Pediatric Kidney Stone Prevention, Part One. J Ren Nutr. 2017 01; 27(1):e5-e8.
    View in: PubMed
    Score: 0.031
  5. Outcomes of two-drug maintenance immunosuppression for pediatric renal transplantation: 10-yr follow-up in a single center. Pediatr Transplant. 2016 Feb; 20(1):49-58.
    View in: PubMed
    Score: 0.029
  6. Blood volume monitoring to achieve target weight in pediatric hemodialysis patients. Pediatr Nephrol. 2004 Apr; 19(4):432-7.
    View in: PubMed
    Score: 0.013
  7. Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol. 2004 Jan; 19(1):91-5.
    View in: PubMed
    Score: 0.013
  8. Genetic testing in children with nephrolithiasis and nephrocalcinosis. Pediatr Nephrol. 2023 08; 38(8):2615-2622.
    View in: PubMed
    Score: 0.012
  9. Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children. Cochrane Database Syst Rev. 2003; (1):CD003966.
    View in: PubMed
    Score: 0.012
  10. Short compared with standard duration of antibiotic treatment for urinary tract infection: a systematic review of randomised controlled trials. Arch Dis Child. 2002 Aug; 87(2):118-23.
    View in: PubMed
    Score: 0.011
  11. Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial. Pediatr Nephrol. 2023 04; 38(4):1075-1086.
    View in: PubMed
    Score: 0.011
  12. Child and caregiver perspectives on access to psychosocial and educational support in pediatric chronic kidney disease: a focus group study. Pediatr Nephrol. 2023 01; 38(1):249-260.
    View in: PubMed
    Score: 0.011
  13. Developing Consensus-Based Outcome Domains for Trials in Children and Adolescents With CKD: An International Delphi Survey. Am J Kidney Dis. 2020 10; 76(4):533-545.
    View in: PubMed
    Score: 0.010
  14. Are conventional stone analysis techniques reliable for the identification of 2,8-dihydroxyadenine kidney stones? A case series. Urolithiasis. 2020 Aug; 48(4):337-344.
    View in: PubMed
    Score: 0.010
  15. Identifying Important Outcomes for Young People With CKD and Their Caregivers: A Nominal Group Technique Study. Am J Kidney Dis. 2019 07; 74(1):82-94.
    View in: PubMed
    Score: 0.009
  16. Child and Parental Perspectives on Communication and Decision Making in Pediatric CKD: A Focus Group Study. Am J Kidney Dis. 2018 10; 72(4):547-559.
    View in: PubMed
    Score: 0.009
  17. Intra-procedural continuous dialysis to facilitate interventional catheterization in pediatric patients with severe renal failure. Catheter Cardiovasc Interv. 2017 Nov 01; 90(5):784-789.
    View in: PubMed
    Score: 0.008
  18. Whole-exome sequencing in the molecular diagnosis of individuals with congenital anomalies of the kidney and urinary tract and identification of a new causative gene. Genet Med. 2017 04; 19(4):412-420.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.